Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4 CAD | +10.50% | +1.27% | +1.27% |
Mar. 14 | Transcript : HLS Therapeutics Inc., Q4 2023 Earnings Call, Mar 14, 2024 | |
Mar. 14 | HLS Therapeutics Reports Q4 2023 Net Loss of US$5.4 Million; Provides 2024 Outlook, Credit Agreement Update | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.27% | 94.35M | |
+15.96% | 70.55B | |
+11.01% | 27.22B | |
-1.96% | 7.99B | |
+1.91% | 7.9B | |
-25.90% | 7.44B | |
+1.40% | 4.64B | |
+3.37% | 4.16B | |
+13.69% | 4.2B | |
-3.52% | 3.96B |
- Stock
- Equities
- Stock HLS Therapeutics Inc. - Toronto S.E.
- News HLS Therapeutics Inc.
- Transcript : HLS Therapeutics Inc., Q3 2021 Earnings Call, Nov 04, 2021